203 related articles for article (PubMed ID: 15785013)
1. Additive beneficial effects of the combination of a calcium channel blocker and an angiotensin blocker on a hypertensive rat-heart failure model.
Kim-Mitsuyama S; Izumi Y; Izumiya Y; Yoshida K; Yoshiyama M; Iwao H
Hypertens Res; 2004 Oct; 27(10):771-9. PubMed ID: 15785013
[TBL] [Abstract][Full Text] [Related]
2. AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure.
Yoshida J; Yamamoto K; Mano T; Sakata Y; Nishikawa N; Nishio M; Ohtani T; Miwa T; Hori M; Masuyama T
Hypertension; 2004 Mar; 43(3):686-91. PubMed ID: 14757777
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment with a calcium channel blocker and an angiotensin blocker in a rat systolic heart failure model with hypertension.
Namba M; Kim S; Zhan Y; Nakao T; Iwao H
Hypertens Res; 2002 May; 25(3):461-6. PubMed ID: 12135327
[TBL] [Abstract][Full Text] [Related]
4. Regression of glomerular and tubulointerstitial injuries by dietary salt reduction with combination therapy of angiotensin II receptor blocker and calcium channel blocker in Dahl salt-sensitive rats.
Rafiq K; Nishiyama A; Konishi Y; Morikawa T; Kitabayashi C; Kohno M; Masaki T; Mori H; Kobori H; Imanishi M
PLoS One; 2014; 9(9):e107853. PubMed ID: 25233358
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of diastolic stiffening of the failing myocardium and its prevention by angiotensin receptor and calcium channel blockers.
Cheng XW; Okumura K; Kuzuya M; Jin Z; Nagata K; Obata K; Inoue A; Hirashiki A; Takeshita K; Unno K; Harada K; Shi GP; Yokota M; Murohara T
J Cardiovasc Pharmacol; 2009 Jul; 54(1):47-56. PubMed ID: 19528815
[TBL] [Abstract][Full Text] [Related]
6. Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure.
Kim S; Yoshiyama M; Izumi Y; Kawano H; Kimoto M; Zhan Y; Iwao H
Circulation; 2001 Jan; 103(1):148-54. PubMed ID: 11136700
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of angiotensin-converting enzyme inhibition on sarcoplasmic reticulum function in the failing heart of the Dahl rat.
Satoh S; Ueda Y; Suematsu N; Oyama J; Kadokami T; Sugano M; Yoshikawa Y; Makino N
Circ J; 2003 Aug; 67(8):705-11. PubMed ID: 12890915
[TBL] [Abstract][Full Text] [Related]
8. Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice.
Suzuki J; Iwai M; Li Z; Li JM; Min LJ; Ide A; Yoshii T; Oshita A; Mogi M; Horiuchi M
J Hypertens; 2005 Jul; 23(7):1383-9. PubMed ID: 15942461
[TBL] [Abstract][Full Text] [Related]
9. Effects of imidapril on endothelin-1 and ACE gene expression in failing hearts of salt-sensitive hypertensive rats.
Kobayashi N; Hara K; Higashi T; Matsuoka H
Am J Hypertens; 2000 Oct; 13(10):1088-96. PubMed ID: 11041163
[TBL] [Abstract][Full Text] [Related]
10. ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure.
Yamamoto K; Mano T; Yoshida J; Sakata Y; Nishikawa N; Nishio M; Ohtani T; Hori M; Miwa T; Masuyama T
J Hypertens; 2005 Feb; 23(2):393-400. PubMed ID: 15662228
[TBL] [Abstract][Full Text] [Related]
11. A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression.
Jia N; Okamoto H; Shimizu T; Chiba S; Matsui Y; Sugawara T; Akino M; Kitabatake A
Hypertens Res; 2003 Sep; 26(9):737-42. PubMed ID: 14620930
[TBL] [Abstract][Full Text] [Related]
12. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients.
Matsui Y; Eguchi K; O'Rourke MF; Ishikawa J; Miyashita H; Shimada K; Kario K
Hypertension; 2009 Oct; 54(4):716-23. PubMed ID: 19667251
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan.
Jinno T; Iwai M; Li Z; Li JM; Liu HW; Cui TX; Rakugi H; Ogihara T; Horiuchi M
Hypertension; 2004 Feb; 43(2):263-9. PubMed ID: 14707152
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
Iwai M; Li HS; Chen R; Shiuchi T; Wu L; Min LJ; Li JM; Tsuda M; Suzuki J; Tomono Y; Tomochika H; Mogi M; Horiuchi M
J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512
[TBL] [Abstract][Full Text] [Related]
15. Renoprotective effects of benidipine in combination with angiotensin II type 1 receptor blocker in hypertensive Dahl rats.
Yao K; Sato H; Ina Y; Suzuki K; Ohno T; Shirakura S
Hypertens Res; 2003 Aug; 26(8):635-41. PubMed ID: 14567503
[TBL] [Abstract][Full Text] [Related]
16. Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria.
Abe M; Maruyama N; Okada K; Matsumoto S; Matsumoto K; Soma M
Hypertens Res; 2011 Aug; 34(8):935-41. PubMed ID: 21654755
[TBL] [Abstract][Full Text] [Related]
17. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
Katayama S; Kawamori R; Iwamoto Y; Saito I; Kuramoto K;
Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of olmesartan and azelnidipine on atrial structural remodeling in spontaneously hypertensive rats.
Okamura K; Ito M; Tanaka K; Chinushi M; Adachi T; Mitsuma W; Hirono S; Nakazawa M; Kodama M; Aizawa Y
Pharmacology; 2009; 83(6):360-6. PubMed ID: 19440002
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction.
Nakamura Y; Yoshiyama M; Omura T; Yoshida K; Izumi Y; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Cardiovasc Res; 2003 Jan; 57(1):48-54. PubMed ID: 12504813
[TBL] [Abstract][Full Text] [Related]
20. Kidney-protective effects of azelnidipine versus a diuretic in combination with olmesartan in hypertensive patients with diabetes and albuminuria: a randomized study.
Kojima M; Okubo S; Mizubayashi R; Isaka N; Machida H; Okamoto S; Hirota H; Takeuchi M; Kato T; Nakatani K; Mizuno O; Miyagawa K; Makino K; Okura T; Dohi Y; Ito M; Kimura G
Nephrol Dial Transplant; 2013 Jul; 28(7):1802-10. PubMed ID: 23535223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
